Advertisement

Topic - Astrazeneca

Related Stories

Britain's Prime Minister Keir Starmer, left, shakes hands with Chinese President Xi Jinping ahead of a bilateral meeting in Beijing, China, Thursday, Jan.29, 2026. (Carl Court/Pool Photo via AP)

Starmer and Xi call for deeper U.K.-China ties as Trump shakes up global relations

By Ken Moritsugu and Jill Lawless - Associated Press

Trump's pharmaceutical drug pricing plan illustration by Alexander Hunter/The Washington Times

Trump is bringing other nations to heel on drug pricing

By Jeffrey Gerrish

President Donald Trump shakes hands with AstraZeneca CEO Pascal Soriot in the Oval Office of the White House, Friday, Oct. 10, 2025, in Washington, as Virginia Gov. Glenn Youngkin and Centers for Medicare & Medicaid Services administrator Dr. Mehmet Oz watch. (AP Photo/Alex Brandon)

Trump strikes deal with AstraZeneca to lower drug prices for Americans

By Jeff Mordock and Kerry Picket - The Washington Times

AstraZeneca announces $50B investment in U.S., including Virginia facility

By Tom Howell Jr. - The Washington Times

Medical staff prepares an AstraZeneca coronavirus vaccine during preparations at the vaccine center in Ebersberg near Munich, Germany, Monday, March 22, 2021. The pharma giant AstraZeneca has requested that its European authorization for its COVID vaccine be pulled, according to the EU medicines regulator on Wednesday, May 8, 2024. (AP Photo/Matthias Schrader, File)

AstraZeneca pulls its COVID vaccine from European market

Associated Press

Medical staff prepares a syringe from a vial of the AstraZeneca coronavirus vaccine during preparations at the vaccine center in Ebersberg near Munich, Germany, Monday, March 22, 2021. AstraZeneca said Thursday that it is withdrawing its application for approval of its COVID-19 vaccine in Switzerland because the country's medical regulator wanted to restrict its use to people over 50. (AP Photo/Matthias Schrader, File)

AstraZeneca withdraws COVID-19 vaccine from worldwide circulation

By Victor Morton - The Washington Times

Persons over 60 years old wait in observation after receiving their second dose of the AstraZeneca COVID-19 vaccine at the University Olympic Stadium in Mexico City, April 12, 2021. (AP Photo/Marco Ugarte) **FILE**

AstraZeneca admits its COVID vaccine can cause deadly blood clots

By Staff - The Washington Times

A Moderna Spikevax COVID-19 vaccine is seen at a drugstore in Cypress, Texas, Sept. 20, 2023. On Thursday, Feb. 1, 2024, the Centers for Disease Control and Prevention said the updated COVID-19 vaccine was 54% effective at preventing symptomatic infection in adults. The shot became available last year as a replacement vaccine designed to better protects against more recent COVID variants. (Melissa Phillip/Houston Chronicle via AP, File)

Study of 99 million COVID-vaccinated people finds links to brain, heart problems

By Staff - The Washington Times

In this Jan. 21, 2021, file photo a medical staff member prepares the Pfizer COVID-19 vaccine at Tudor Ranch in Mecca, Calif. With vaccination against COVID-19 in full swing, social platforms like Facebook, Instagram and Twitter say they’ve stepped up their fight against misinformation that aims to undermine trust in the vaccines. (AP Photo/Jae C. Hong, File)

‘Twitter Files’: Big Pharma pressured platform to censor COVID-19 vaccine debate

By Joseph Clark - The Washington Times

FILE - Syringes and colorful bandages are prepared as children from local schools prepare to get COVID-19 vaccines in Pittsfield, Mass., on Monday Dec. 13, 2021. A review by federal health officials finds that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently eligible for vaccination. The review issued Sunday, June 12, 2022, by the Food and Drug Administration is a key step toward a decision on vaccinations for babies, toddlers and preschoolers, perhaps as soon as June 21. (Ben Garver/The Berkshire Eagle via AP, File)

Pfizer, BioNTech now siccing experimental COVID shots on babies

By Cheryl K. Chumley - The Washington Times

COVID-19 nasal spray fails in trial by Oxford University and AstraZeneca

By Tom Howell Jr. - The Washington Times

FILE - Professor Dame Sarah Gilbert on June 11, 2021. In excerpts released ahead of a speech Monday Dec. 6, 2021, Prof. Sarah Gilbert, one of the scientists behind the Oxford-AstraZeneca COVID-19 vaccine, is warning that the next pandemic may more contagious and more lethal unless more money is devoted to research and preparations to fight emerging viral threats. (Steve Parsons/PA via AP, file)

Big Pharma, WHO, globalists tee up next virus fear

By Cheryl K. Chumley - The Washington Times

The French vaccine startup Valneva headquarters is pictured in Saint-Herblain, western France, Wednesday, Feb. 3, 2021. French pharmaceutical startup Valneva had big news in September: a government contract for 60 million doses of its coronavirus vaccine candidate. The buyer? The United Kingdom — not the European Union, as might be expected for a company on the banks of the Loire. (AP Photo/David Vincent)

French drugmaker Valneva reports positive COVID-19 vaccine results

By Tom Howell Jr. - The Washington Times

Eric Clapton, center, performs during his &quot;70th Birthday Celebration&quot; concert at Madison Square Garden on Friday, May 1, 2015, in New York. (Luiz C. Ribeiro/Invision/AP) ** FILE **

Eric Clapton plays arena with COVID-19 vaccine requirement, despite anti-mandate stance

By Tom Howell Jr. - The Washington Times

FILE - In this April 8, 2021 file photo, the Johnson &amp; Johnson COVID-19 vaccine is seen at a pop up vaccination site in the Staten Island borough of New York. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine bulk substance to resume, the company said Thursday, July 29. The Baltimore factory was shut down by the FDA in mid-April due to contamination problems that forced the company to trash the equivalent of tens of millions of doses of vaccine it was making under contract for Johnson &amp; Johnson. (AP Photo/Mary Altaffer, File)

Emergent: FDA letting troubled COVID vaccine factory restart

By Linda A. Johnson - Associated Press